Lisa Situ, PhD
@lisasitu
Followers
291
Following
294
Media
3
Statuses
61
Assistant Editor at Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard PhD ‘24 and proud @UCLA Bruin. Views are my own.
Joined May 2009
RT @CD_AACR: Attending #AACRprecmed25? Assistant Editor @lisasitu, PhD, is looking forward to answering your questions about publishing in….
0
3
0
RT @UCLAHealthJCCC: UCLA scientists identified 223 genetic mutations that drive prostate cancer evolution. Their findings, published in @CD….
0
5
0
RT @ElizSMcKenna: Exciting news for the cancer research community! Read more about the new challenges now in @CD_AACR: .
0
14
0
RT @CD_AACR: Read this week's Cancer Discovery #ResearchWatch: High-risk ER+ #BreastCancers Genomically Resemble H….
0
3
0
RT @CD_AACR: ICYMI: "Patient-Specific Hematologic Setpoints Inform Diagnosis and Prognosis" A #ResearchWatch summar….
0
2
0
RT @CD_AACR: ICYMI: "GDF-15 Blockade Overcomes Resistance to Immune Checkpoint Inhibition" A #ResearchWatch summary….
0
5
0
RT @VivekSubbiah: ⭐️Such a pleasure to meet @lisasitu Assistant Editor @CD_AACR @AACR .Her insightful questions on my talk on trial designs….
0
5
0
Heading to Breckenridge bright and early tomorrow morning - hope to see you there! Don’t hesitate to send me a DM if you’d like to connect. Looking forward to #KSPrecisionOnc25.
Attending @KeystoneSymp Precision Oncology: Emerging Technologies & Implementation? If you'd like to discuss your research or have questions about publishing in Cancer Discovery, please reach out to Assistant Editor Lisa Situ, PhD, during or after the meeting. #KSPrecisionOnc25
0
1
9
It was our pleasure - congratulations to you and the whole team on the publication of these important findings for the field of breast cancer dormancy and metastasis!.
0
0
9
RT @ElizSMcKenna: I'm so excited to be able to share this new @CD_AACR paper by @arizonaevo, @zooexoticcancer, @evilsmaug, @jdschiffman, @A….
0
34
0
RT @GametoGen: 🎉 We have been selected by @ARPAHealth as an awardee of the #SprintForWomensHealth and will receive $10 million in funding f….
0
3
0
RT @ElizSMcKenna: Now online in @CD_AACR, for #ENA2024: The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Developme….
0
16
0
Congratulations, Amy and the whole team! Such beautiful work and a very interesting mechanism. It has been a joy to have been in the lab to watch it develop into this exciting tour de force! Very optimistic about this combo for TNBC.
Newest work from our group led by Amy Schade shows that EZH2 and AKT inhibitors combine to induce shrinkage of TNBC tumors by hijacking mechanisms of involution, now published in @Nature
0
0
4
Thank you for highlighting our review on combinatorial strategies to target RAS-driven cancer! It was a great experience diving deep into promising therapeutic strategies with compelling preclinical evidence with @CichowskiLab and I hope this review inspires much more research!.
Preparing for the next #ENASymp24 session on Inhibiting KRAS in the clinic beyond G12C?.Get ahead by reading our recent #Review on the topic by Cichowski and colleagues:
0
0
4
RT @ElizSMcKenna: The October issue of @CD_AACR is online! The cover features features work by @TobyBaker97, @MaxGalder, @VanLooLab and co….
0
3
0
RT @ElizSMcKenna: #AACRpan24 starts tonight in Boston! @lisasitu and Robert Kruger will be there if you would like to discuss your research….
0
6
0
Thank you so much for the warm welcome! I am so grateful to be a part of the team 🤗.
I am thrilled to announce that @lisasitu has joined @CD_AACR as our new Assistant Editor! Lisa joins us from the @CichowskiLab and was a member of the @ChristofkLab before coming to the East Coast. She has also written for CD Research Watch✍️for the past 3 years - Welcome, Lisa!
1
0
26